BOTULINUM TYPE-F NEUROTOXIN - LARGE-SCALE PURIFICATION AND CHARACTERIZATION OF ITS BINDING TO RAT CEREBROCORTICAL SYNAPTOSOMES

1. A large-scale purification procedure has been developed for Clostridium botulinum type F neurotoxin. Commencing with 160 litres of bacterial culture, 101 mg of purified type F neurotoxin with a specific toxicity of 2 x 107 mouse LD50 (median lethal dose)·mg-1 were obtained. 2. Purified type F neurotoxin was labelled to high specific radioactivity (900-1360 Ci/mmol) without loss of biological activity using a chloramine-T procedure. Of the two neurotoxin subunits, the heavy chain was preferentially radiolabelled. 3. Radiolabelled type F neurotoxin displayed specific saturable binding to rat synaptosomes. At least two pools of acceptors were evident: a low content of high-affinity acceptors sites [K(D) ~ 0.15 nM; B(max) (maximal binding) 20 fmol/mg] and a larger pool of lower-affinity sites (K(D) > 20 nM; B(max) > 700 fmol/mg). Both pools of acceptors were sensitive to trypsin and neuraminidase treatment, which suggests that protein and sialic acid residues are components of the synaptosomal acceptors. 4. Experiments investigating competition among botulinum neurotoxin types A, B, E and F for acceptors on rat brain synaptosomes that showed type F neurotoxin binds to acceptor molecules which are completely distinct from those of the other three neurotoxins.